NDATOPICALCREAM
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
10
Data completeness
4/8 — Partial
SSD (silver sulfadiazine) by Dr. Reddy's Laboratories is clinical pharmacology silver sulfadiazine has broad antimicrobial activity. First approved in 1982.
Drug data last refreshed 11h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Silver sulfadiazine is a topical cream combining silver and sulfonamide chemistry for broad-spectrum antimicrobial activity against gram-positive, gram-negative bacteria, and yeast. It acts bactericidally on bacterial cell walls and is indicated for burn wound management and infection prevention in patients with thermal injuries. The mechanism differs from silver nitrate and sodium sulfadiazide alone, making it effective against resistant organisms.
$5MPart D
LOE ApproachingProduct is approaching loss of exclusivity with modest Part D spending (~$5M), suggesting a niche wound-care franchise with limited team expansion opportunity.
Mechanism of Action
CLINICAL PHARMACOLOGY Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram-negative and gram-positive bacteria as well as being effective against yeast. Results from in vitro testing are listed below. Sufficient data have been obtained to demonstrate that silver…
Pharmacologic Class:
Sulfonamide Antibacterial
Indications
Worked on SSD at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.